News All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen Staff January 26, 2024 Please read the full announcement in PDF Attachment 2024_01_All_Regulatory_Approvals_Obtained Iframe sync Post navigation Previous: Additional ODM-208/MK-5684 Phase II data presented at ASCO-GU 2024Next: All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen More Stories Healthcare News Pharmaceutical ADM Tronics Reports Second Quarter of Fiscal Year 2027 Results Staff November 16, 2026 Healthcare News Pharmaceutical Pregnancy Aytu BioPharma Reports Fiscal 2027 First Quarter Operational and Financial Results Staff November 16, 2026 Clinical Trial Healthcare News Pharmaceutical Ensysce Biosciences Announces Participation in Upcoming Investor Conferences Staff November 16, 2026